LEQSELVI 8 MG Oral Tablet
- RxCUI
- 2716569
- RxNorm name
- LEQSELVI 8 MG Oral Tablet
- Display name
- LEQSELVI 8 MG Oral Tablet
- Full name
- LEQSELVI 8 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEQSELVI | DEURUXOLITINIB PHOSPHATE | Sun Pharmaceutical Industries, Inc. | a603f231-d09e-4bad-ad5e-b55f865da095 | 2026-07-13 | Boxed warning, Warnings, Adverse reactions | 2716569 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a603f231-d09e-4bad-ad5e-b55f865da095 | LEQSELVI 8 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use LEQSELVI safely and effectively. See full prescribing information for LEQSELVI. LEQSELVI™ (deuruxolitinib) tablets, for oral use Initial U.S. Approval: 2024 | 20250717 |
| a603f231-d09e-4bad-ad5e-b55f865da095 | deuruxolitinib 8 MG Oral Tablet [Leqselvi] | SBD | 11 | These highlights do not include all the information needed to use LEQSELVI safely and effectively. See full prescribing information for LEQSELVI. LEQSELVI™ (deuruxolitinib) tablets, for oral use Initial U.S. Approval: 2024 | 20250717 |
| a603f231-d09e-4bad-ad5e-b55f865da095 | Leqselvi 8 MG Oral Tablet | SY | 11 | These highlights do not include all the information needed to use LEQSELVI safely and effectively. See full prescribing information for LEQSELVI. LEQSELVI™ (deuruxolitinib) tablets, for oral use Initial U.S. Approval: 2024 | 20250717 |